Cordlife Parents
We are focused on helping people live healthier, happier and longer by providing reliable healthcare solutions through innovation, technological advancement and commitment to quality.
July 2004
National Institutes of Healthnews US$272,000 Cygenics Contract
June 2004
Cord Blood Stem Cells Transplant a Success
Cygenics IPO oversubscribed
May 2004
CyGenics To List on Australian Stock Exchange
April 2004
Cell Sciences Signs On European Distributor
Cordlife Aims for Future Growth as Cygenics
March 2004
Preliminary Final Report
Asian Cord Blood Banks Form Consortium
CyGenics secures exclusive licence on enhanced T cell production technologies from the Brigham and Women’s Hospital
